DH

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

Wall Street analysts forecast DH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DH is 3.52 USD with a low forecast of 3.00 USD and a high forecast of 4.06 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Definitive Healthcare Corp revenue for the last quarter amounts to 60.05M USD, decreased -4.23 % YoY.

Definitive Healthcare Corp. EPS for the last quarter amounts to -0.14 USD, decreased -87.50 % YoY.

Definitive Healthcare Corp (DH) has 782 emplpoyees as of December 15 2025.

Today DH has the market capitalization of 327.22M USD.